Naturopaths vs. Science: Let's Take a Look at the Science Behind

Share Article

Nonconventional medical treatments have become increasingly mainstream. But why are patients willing to become their own experiment? The July issue of The Scientist magazine hosts a number of articles covering the rising trend of natural treatments and why people may be taking science into their own hands, for better or for worse.

Alternative Medicines July 2012 The Scientist Exploring Life Inspiring innovation

July 2012 Issue of The Scientist Magazine

Nonconventional medical treatments have become increasingly mainstream, in some cases, despite the lack of rigorous evidence. This trend is driven by patients who are demanding the integration of alternative or complementary treatments...

In the July issue of The Scientist magazine, the editorial team reports on the scientific evidence that certain alternative treatments—acupuncture, probiotics, marijuana, and psychedelics—are beneficial to patients. Nonconventional medical treatments have become increasingly mainstream, in some cases, despite the lack of rigorous evidence. This trend is driven by patients who are demanding the integration of alternative or complementary treatments for conditions that are difficult to manage or cure, such as diabetes, chronic pain, and cancer. The articles highlight the circumstances that hinder the broader acceptance and study of medicinal marijuana, the incomplete evidence for the effectiveness of probiotics, the reasons why acupuncture might work, and the promising benefits of psychedelics in treating cognitive diseases. Often, the data both support and contravene the effectiveness of these alternative therapies, uncovering both positive and negative aspects of treatments for which patients are clamoring and both physicians and informed minds are demanding evidence.

The issue also includes an opinion piece calling for all physicians to become more aware of the dangers (and benefits) of mixing herbal remedies with prescription drugs and an article about a group of ALS patients who have taken fate into their own hands by launching do-it-yourself trials using a chemical they believe to be the active ingredient in a drug under development.

Follow Us:
Facebook @ http://www.facebook.com/TheScientistMagazine
Twitter @ http://www.twitter.com/thescientistllc
LinkedIn @ http://www.linkedin.com/groups/Scientist-Magazine-2142072
ABOUT THE SCIENTIST
The Scientist has informed and entertained life science professionals around the world for more than 25 years. We provide print and online coverage of the latest developments in the life sciences including trends in research, new technology, news, business and careers. We reach the leaders in academia and industry that are interested in maintaining a broad view of the life sciences by reading insightful articles that are current, concise and entertaining.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jef Akst
Follow us on
Visit website